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“Safe And Effective Deprescribing of Anticholinergics (SEDA)” project, led by 
Regenstrief Institute and IU Center for Aging and Eskenazi, focuses on patient 
safety harms from medications with anticholinergic effects. Drugs with 
anticholinergic effects have been implicated in cognitive impairment in older 
adults. 
 
The Rethinking Brain Health research project was conducted in the course of 
Collaborative Action Research in Design. Our team adopted a people-centered 
design approach, aimed to develop a behavioral and cultural understanding of 
brain safety issues related to anticholinergic medication. At the beginning of the 
research, we identified the key stakeholders as patients, family and community 
support, caregivers, registered nurses, care coordinators, pharmacists, primary 
doctors, and geriatricians in order to understand the complexity of the problems 
from multiple perspectives and a systematic view. 
 
The poster identifies 3 different personas that exemplify the major characteristics 
from the patients interviewed such as their communication with their provider, the 
sources of support, and their quality of life. It also shows the relationship between 
the patient and providers. 
 
By using research methods, we were able to gain a contextual understanding of 
the behaviors and the needs of patients and caregivers. This gigamap poster 
serves as a tool to reveal the interconnectedness of the problems associated 
with the patients’ experience with anticholinergics from the perspective of both 
the patient and provider. A deep understanding of the problems associated with 
anticholinergics helped us to identify the opportunity areas as assisting the 
patients’ support system in playing an active role in health decisions, assisting 
the patient in taking ownership of their health decisions and developing a holistic 
approach to treatment options, and creating a better information system between 
providers. Framing the problems into opportunities allows the SEDA team to take 
the next appropriate actionable steps in identifying appropriate solutions.  
 
 
 
